NAD+
A foundational pyridine-dinucleotide coenzyme studied as a redox cofactor and enzymatic cosubstrate across bioenergetics, DNA-repair signaling, and protein-deacylation research.
View NAD+ in the storeMolecular Profile
- Type
- Pyridine-dinucleotide coenzyme
- Molecular formula
- C21H27N7O14P2
- Molecular weight
- 663.43 g/mol
- CAS number
- 53-84-9
Mechanism & Target Class
NAD+ operates through two broad biochemical modes. As a redox cofactor, it accepts a hydride at the C4 position of its nicotinamide ring to form NADH — a reversible reaction exploited by hundreds of oxidoreductases and dehydrogenases that bind it through a conserved βαβ Rossmann-fold dinucleotide-binding motif. As a consumable cosubstrate, NAD+ is cleaved at the glycosidic bond between nicotinamide and the ADP-ribose moiety by three signaling-enzyme families: poly(ADP-ribose) polymerases (PARPs/ARTDs), which transfer ADP-ribose units onto acceptor proteins in DNA-damage responses; sirtuins (SIRT1–7), NAD+-dependent protein deacylases that couple acyl-lysine mark removal to production of nicotinamide and 2′-O-acyl-ADP-ribose; and NAD+ glycohydrolases/ADP-ribosyl cyclases (CD38, CD157/BST1, and the TIR-domain NADase SARM1). Cellular NAD+ pools are compartmentalized across the cytosol, nucleus, and mitochondria, with SLC25A51 identified as a mammalian mitochondrial NAD+ transporter.
Storage & Handling
- Lyophilized
- -20°C long term; store desiccated, sealed from air, and protected from light. NAD+ is hygroscopic.
- Handling
- Hygroscopic in solid state; aqueous NAD+ is labile and degrades with heat, alkaline pH, and repeated freeze-thaw. Aliquot working solutions to limit hydrolysis.
Primary Database
References (22)
Reviews
1Navas LE, Carnero A (2022). Cells
- 2
Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021). Nature Reviews Molecular Cell Biology
- 3
Katsyuba E, Romani M, Hofer D, Auwerx J (2020). Nature Metabolism
- 4
Alemasova EE, Lavrik OI (2019). Nucleic Acids Research
- 5
Chini CCS, et al. (2018). Trends in Pharmacological Sciences
- 6
Cantó C, Menzies KJ, Auwerx J (2015). Cell Metabolism
- 7
Houtkooper RH, Cantó C, Wanders RJ, Auwerx J (2010). Endocrine Reviews
Clinical
8Wang DD, et al. (2025). eClinicalMedicine
- 9
et al. (2023). PubMed
- 10
Yoshino M, Yoshino J, et al. (2021). Science
- 11
Martens CR, Denman BA, Mazzo MR, et al. (2018). Nature Communications
- 12
Elhassan YS, et al. (2017). J Endocr Soc
- 13
Trammell SAJ, Schmidt MS, Weidemann BJ, et al. (2016). Nature Communications
Primary research
14Luongo TS, Eller JM, Lu MJ, et al. (2020). Nature
- 15
Girardi E, Agrimi G, Goldmann U, et al. (2020). Nature Communications
- 16
Jiang Y, Liu T, Lee CH, Chang Q, Yang J, Zhang Z (2020). Nature
- 17
Katsyuba E, Mottis A, Zietak M, et al. (2018). Nature
- 18
Essuman K, Summers DW, Sasaki Y, et al. (2017). Neuron
- 19
Camacho-Pereira J, Tarragó MG, Chini CCS, et al. (2016). Cell Metabolism
- 20
Mills KF, Yoshida S, Stein LR, et al. (2016). Cell Metabolism
- 21
Bieganowski P, Brenner C (2004). Cell
- 22
Imai S, Armstrong CM, Kaeberlein M, Guarente L (2000). Nature
